CryoCell International Inc (CCEL)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • AMEX
Market Cap: $39.10M
Last updated: Nov 17, 2026 at 11:04 AM ET
CryoCell International Inc (CCEL) Stock Forecast
Analysts expect CryoCell International (CCEL) to earn $0.11 per share in the fiscal year ending Nov 30, 2026, on revenue of $30.04M. Over the last 30 days, 1 estimate for the fiscal year ending Nov 30, 2026 was revised up and 0 down. For the fiscal year ending Nov 30, 2027, the EPS consensus is $0.07.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 36.4% and revenue estimates rise 4.9%.
- Fiscal year ending Nov 30, 2026
- $0.11
- EPS consensus, revenue $30.04M
- Fiscal year ending Nov 30, 2027
- $0.07
- EPS consensus, revenue $31.50M
- Next report
- Feb 25, 2027
- Estimated
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $0.11 | $0.11 to $0.11 | 1 | $30.04M | $30.04M to $30.04M | 1 |
| Nov 30, 2027 | $0.07 | N/A | 1 | $31.50M | $31.50M to $31.50M | 1 |
Quarterly Estimates
The EPS consensus falls from $0.05 for the quarter ending Nov 30, 2026 to $0.02 for the quarter ending Feb 28, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Nov 30, 2026 | $0.05 | $0.05 to $0.05 | 3 | $7.50M | $7.21M to $7.72M | 3 |
| Feb 28, 2027 | $0.02 | $0.02 to $0.02 | 1 | $7.25M | $7.25M to $7.25M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Nov 30, 2026 | 1 | 0 |
| Fiscal year ending Nov 30, 2027 | 1 | 0 |
| Quarter ending Feb 28, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Nov 30, 2026 has turned from a loss of $0.42 to a profit.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Nov 30, 2026 | $0.11 | $0.08 | $0.08 | -$0.42 | -$0.42 | N/A |
| Fiscal year ending Nov 30, 2027 | $0.07 | -$0.11 | -$0.11 | -$0.11 | -$0.11 | N/A |
Frequently Asked Questions About CCEL
What is the CCEL stock forecast?
Consensus analyst estimates put CryoCell International's EPS at $0.11 for the fiscal year ending Nov 30, 2026, on revenue of $30.04M.
What EPS do analysts expect from CCEL next year?
For the fiscal year ending Nov 30, 2026, the consensus EPS estimate is $0.11, with estimates from $0.11 to $0.11 from 1 analyst. For the fiscal year ending Nov 30, 2027, the consensus EPS estimate is $0.07 from 1 analyst.
What revenue do analysts expect from CryoCell International next year?
For the fiscal year ending Nov 30, 2026, the consensus revenue estimate is $30.04M, with estimates from $30.04M to $30.04M. For the fiscal year ending Nov 30, 2027, the consensus revenue estimate is $31.50M, with estimates from $31.50M to $31.50M.
How many analysts cover CCEL?
1 analyst estimates EPS for CryoCell International for the fiscal year ending Nov 30, 2026.
CCEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors